Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 26, 2021

Primary Completion Date

July 29, 2024

Study Completion Date

January 7, 2025

Conditions
Malaria, Vivax
Interventions
DRUG

Primaquine

7 days of unsupervised primaquine (3.5 mg/kg total dose) administered once per day (0.5 mg/kg OD).

DRUG

Primaquine

7 days of unsupervised primaquine (7.0 mg/kg total dose) administered once per day (1.0 mg/kg OD).

DRUG

Primaquine

14 days of unsupervised primaquine (7mg/kg total dose) administered once per day (0.5 mg/kg).

Trial Locations (2)

Unknown

Universidade Federal do Acre, Cruzeiro do Sul

69040-000

Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

lead

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

OTHER

NCT05044637 - Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in Children | Biotech Hunter | Biotech Hunter